Empiric potassium supplementation and increased survival in users of loop diuretics

PLoS ONE

Volumn 9, Issue 7, 2014, Pages

  Leonard, Charles E ^a   Razzaghi, Hanieh ^a   Freeman, Cristin P ^a   Roy, Jason A ^a   Newcomb, Craig W ^a   Hennessy, Sean ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUMETANIDE; ETACRYNIC ACID; FUROSEMIDE; POTASSIUM; TORASEMIDE; LOOP DIURETIC AGENT;

ADULT; AGED; ARTICLE; COHORT ANALYSIS; DRUG INDICATION; DRUG SAFETY; DRUG USE; FEMALE; FOLLOW UP; HEART DEATH; HEART VENTRICLE ARRHYTHMIA; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; OBSERVATIONAL STUDY; PREDICTIVE VALUE; PROPENSITY SCORE; RISK ASSESSMENT; RISK REDUCTION; SURVIVAL RATE; VITAMIN SUPPLEMENTATION; ADOLESCENT; ARRHYTHMIAS, CARDIAC; CHEMICALLY INDUCED; DEATH, SUDDEN, CARDIAC; DIETARY SUPPLEMENT; MIDDLE AGED; SURVIVAL ANALYSIS; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ARRHYTHMIAS, CARDIAC; COHORT STUDIES; DEATH, SUDDEN, CARDIAC; DIETARY SUPPLEMENTS; FEMALE; HUMANS; MALE; MIDDLE AGED; POTASSIUM; SODIUM POTASSIUM CHLORIDE SYMPORTER INHIBITORS; SURVIVAL ANALYSIS; YOUNG ADULT;

EID: 84904341225     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0102279     Document Type: Article

References (30)

1. Sica DA, Carter B, Cushman W, Hamm L (2011) Thiazide and loop diuretics. J Clin Hypertens (Greenwich) 13(9):639-643. PubMed: 21896142.
2. van Kraaij DJ, Jansen RW, Gribnau FW, Hoefnagels WH (1998) Loop diuretics in patients aged 75 years or older: general practitioners' assessment of indications and possibilities for withdrawal. Eur J Clin Pharmacol 54(4):323-327. PubMed: 9696957.
3. Sica DA (2004) Diuretic-related side effects: Development and treatment. J Clin Hypertens (Greenwich) 6(9):532-540. PubMed: 15365284.
4. MacMahon S, Collins G, Rautaharju P, Cutler J, Neaton J, et al. (1989) Electrocardiographic left ventricular hypertrophy and effects of antihypertensive drug therapy in hypertensive participants in the Multiple Risk Factor Intervention Trial. Am J Cardiol 63(3):202-210. PubMed: 2521269.
5. Holland OB, Nixon JV, Kuhnert L (1981) Diuretic-induced ventricular ectopic activity. Am J Med 70(4):762-768. PubMed: 7211912.
6. Cohn JN, Kowey PR, Whelton PK, Prisant LM (2000) New guidelines for potassium replacement in clinical practice: A contemporary review by the national council on potassium in clinical practice. Arch Intern Med 160(16):2429-2436. PubMed: 10979053.
7. Rose BD (2012) Diuretic-induced hypokalemia. UpToDate Topic 2355: Version 4.0. http://web.archive.org/web/20120927044502/http://www.uptodate.com/ contents/diuretic-induced-hypokalemia. Literature review current through: 10/2012. Last updated: 05/10/2010. Last accessed: 04/03/2014.
8. Hennessy S, Carson JL, Ray WA, Strom BL (2005) Medicaid databases. In: Strom BL, ed. Pharmacoepidemiology. 4th ed. Sussex: John Wiley.
9. Kaiser Family Foundation (2011) Medicaid enrollment: June 2010 data snapshot. Publication #8050-03. kaiserfamilyfoundation.files.wordpress.com/2013/ 01/8050-03.pdf. Last accessed: 04/02/2014.
10. Holahan J, Ghosh A (2005) Dual eligibles: Medicaid enrollment and spending for Medicare beneficiaries in 2003. Kaiser Family Foundation. Publication #7346: 1-24. http://www.kff.org/medicaid/7346.cfm. Last accessed: 04/02/2014.
11. Holahan J, Miller DM, Rousseau D (2009) Dual eligibles: Medicaid enrollment and spending for Medicare beneficiaries in 2005. Kaiser Family Foundation. Publication #7846: 1-17. http://web.archive.org/web/20110608201215/ http://www.kff.org/medicaid/upload/7846.pdf. Last accessed: 04/03/2014.
12. Rousseau D, Clemans-Cope L, Lawton E, Langston J, Connolly J, et al. (2010) Dual eligibles: Medicaid enrollment and spending for Medicare beneficiaries in 2007. Kaiser Family Foundation. Publication #7846-02: 1-17. http://www.ncbi.nlm.nih.gov/nlmcatalog/101560987. Last accessed: 04/02/2014.
13. Austin PC (2011) Optimal caliper widths for propensity-score matching when estimating differences in means and differences in proportions in observational studies. Pharm Stat 10(2):150-161. PubMed: 20925139.
14. Ruppert D, Wand M, Carroll R (2003) Semiparametric Regression. Cambridge: The Press Syndicate of the University of Cambridge.
15. Abildstrom SZ, Køber L, Torp-Pedersen C (1999) Epidemiology of arrhythmic and sudden death in the chronic phase of ischemic heart disease. Card Electrophysiol Rev 3(3):177-179. doi: 10.1023/A:1009971104937.
16. Hennessy S, Leonard CE, Freeman CP, Deo R, Newcomb C, et al. (2010) Validation of diagnostic codes for outpatient-originating sudden cardiac death and ventricular arrhythmia in Medicaid and Medicare claims data. Pharmacoepidemiol Drug Saf 19(6):555-562. PubMed: 19844945.
17. Leonard CE, Freeman CP, Deo R, Newcomb C, Kimmel SE, et al. (2010) Response to commentary entitled "commentary on the validation studies of sudden cardiac death and ventricular arrhythmia by Hennessy et al. and Chung et al.". Pharmacoepidemiol Drug Saf 19(6):576-576. In PubMed: 20087851.
18. Normand ST, Landrum MB, Guadagnoli E, Ayanian JZ, Ryan TJ, et al. (2001) Validating recommendations for coronary angiography following acute myocardial infarction in the elderly: a matched analysis using propensity scores. J Clin Epidemiol 54(4):387-398. PubMed: 11297888.
19. Grams ME, Plantinga LC, Hedgeman E, Saran R, Myers GL, et al. (2011) Validation of CKD and related conditions in existing data sets: A systematic review. Am J Kidney Dis 57(1):44-54. PubMed: 20692079.
20. Altman DG, Andersen PK (1999) Calculating the number needed to treat for trials where the outcome is time to an event. BMJ 319(7223):1492-1495. PubMed: 10582940.
21. Henz S, Maeder MT, Huber S, Schmid M, Loher M, et al. (2008) Influence of drugs and comorbidity on serum potassium in 15 000 consecutive hospital admissions. Nephrol Dial Transplant 23(12):3939-3945. PubMed: 18614817.
22. Ahmed MI, Ekundayo OJ, Mujib M, Campbell RC, Sanders PW, et al. (2010) Mild hyperkalemia and outcomes in chronic heart failure: a propensity matched study. Int J Cardiol 144(3):383-388. PubMed: 19500863.
23. Green DM, Ropper AH, Kronmal RA, Psaty BM, Burke GL, et al. (2002) Serum potassium level and dietary potassium intake as risk factors for stroke. Neurology 59(3):314-320. PubMed: 12177362.
24. Siscovick DS, Raghunathan TE, Psaty BM, Koepsell TD, Wicklund KG, et al. (1994) Diuretic therapy for hypertension and the risk of primary cardiac arrest. N Engl J Med 330(26):1852-1857. PubMed: 8196728.
25. Siegel D, Hulley SB, Black DM, Cheitlin MD, Sebastian A, et al. (1992) Diuretics, serum and intracellular electrolyte levels, and ventricular arrhythmias in hypertensive men. JAMA 267(8):1083-1089. PubMed: 1735925.
26. Ekundayo OJ, Adamopoulos C, Ahmed MI, Pitt B, Young JB, et al. (2010) Oral potassium supplement use and outcomes in chronic heart failure: A propensity-matched study. Int J Cardiol 141(2):167-174. PubMed: 19135741.
27. The SOLVD Investigators (1990) Studies of left ventricular dysfunction (SOLVD)-rationale, design, and methods: 2 trials that evaluate the effect of enalapril in patients with reduced ejection fraction. Am J Cardiol 66(3):315-322. PubMed: 2195865.
28. Cooper HA, Dries DA, Davis CE, Shen YL, Domanski MJ (1999) Diuretics and risk of arrhythmic death in patients with left ventricular dysfunction. Circulation 100(12):1311-1315. PubMed: 10491376.
29. Garg AX, Clark WF, Haynes RB, House AA (2002) Moderate renal insufficiency and the risk of cardiovascular mortality: results from the NHANES I. Kidney Int 61(4):1486-1494. PubMed: 11918756.
30. Culleton BF, Larson MG, Wilson PW, Evans JC, Parfrey PS, et al. (1999) Cardiovascular disease and mortality in a community-based cohort with mild renal insufficiency. Kidney Int 56(6):2214-2219. PubMed: 10594797.